The honest 2026 trade-off on GLP-1 medications: substantial weight loss and cardiometabolic benefits balanced against GI side effects, cost, lean-mass loss risk, and long-term maintenance. Compares branded vs compounded options and where PlexusDx Weight Management Protocols fit at $129–$509/mo across six protocols.

An honest read on the cons of GLP-1 therapy — GI side effects, the boxed warning, cost, weight regain on cessation, and body composition — plus where PlexusDx Weight Management Protocols ($129–$325/mo, all 50 states, no membership) fit when insurance friction is itself one of the cons.

Emerging research suggests GLP-1 receptor agonists like semaglutide and tirzepatide may reduce cravings for alcohol and other substances by modulating dopamine signaling in the brain’s reward circuitry — the same “food noise” mechanism that drives weight-loss outcomes. No GLP-1 is FDA-approved for any addiction indication. This guide explains what the human evidence actually shows, substance by substance, and how PlexusDx Weight Management Protocols are positioned for chronic weight management only.

Compounding pharmacy shut down or lost 503A status for GLP-1s? A 2026 patient continuity guide: first 24-hour checklist, the four scenarios, what a warning letter actually means, three pharmacy-verification lookups, and how PlexusDx Semaglutide Injection ($179-$229/mo), Tirzepatide Injection ($229-$309/mo), Microdose GLP-1 Protocol ($129/mo), GLP-Squared ($179-$325/mo), and the Precision Peptide Genetic Test ($99 add-on) handle transfer patients.

The seven non-negotiable questions to ask before any GLP-1 telehealth consult, with green/yellow/red answer guides — pharmacy identity (503A vs 503B), compounded vs FDA-approved, total cost across month one through highest maintenance dose, escalation path, and the genetic-baseline question most cash-pay platforms skip.

Ozempic nausea is real, dose-related, and highly responsive to specific food and timing choices. This guide covers what to eat right now (bland, low-fat, small portions), what to drink (room-temp water, ginger tea, broth), what to avoid (fatty/fried/spicy/carbonated), and when to call a clinician. Plus how PlexusDx Semaglutide Injection ($179–$229/mo), the Microdose GLP-1 Protocol ($129/mo flat), and the Optimal Diet & Weight Loss Genetic Test ($298) fit into a tolerable, sustainable GLP-1 plan.

FDA labels list hair loss in 3% of Wegovy and 4–5% of Zepbound users, but the real trigger is rapid weight loss producing telogen effluvium — a reversible 6–12 month shedding pattern. This guide covers the FDA evidence, the timeline you can plan around, why women report it more often, the genetic variants behind GLP-1 response, and how a slower-titration PlexusDx protocol plus the Precision Peptide Genetic Test reduces risk before week one.

Practical, food-by-food playbook for managing Zepbound (tirzepatide) nausea: what to eat in the first 24 hours after your shot, what to drink, what to avoid, when to call your doctor, and how genetic variants in GLP1R, GIPR, and gastric-emptying genes explain why some patients are far more sensitive than others. Includes how PlexusDx Tirzepatide Injection ($229-$309/mo) and Tirzepatide Oral ($229-$509/mo) compounded protocols, paired with the Precision Peptide Genetic Test, let your clinician anchor titration to your biology.

Mounjaro side effects from the FDA-approved label — common GI reactions (nausea, vomiting, diarrhea, constipation, abdominal pain), less common serious reactions (pancreatitis, gallbladder disease, acute kidney injury), and the boxed warning for thyroid C-cell tumors with MTC and MEN 2 contraindications. Plus how compounded tirzepatide protocol oversight from PlexusDx Tirzepatide Injection ($229–$309/mo) and Tirzepatide Oral ($229–$509/mo) compares, and where the Precision Peptide Genetic Test fits as a $99 add-on for GLP1R, GIPR, FTO, MC4R, and TCF7L2 baseline.

Constipation is one of the most common GLP-1 side effects — here's the food, fluid, movement, and dose-adjustment playbook that actually works, plus where the PlexusDx Microdose GLP-1 Protocol and Precision Peptide Genetic Test fit in.

What's common, what's serious, and how to manage GLP-1 side effects from FDA-labeled known information — including the boxed warning that applies to both semaglutide and tirzepatide, when to call your provider, and how PlexusDx structures titration and the optional Precision Peptide Genetic Test.

503A vs 503B compounding pharmacy explained — the regulatory framework, FDA Modernization Act of 1997 and Drug Quality and Security Act of 2013, oversight differences, and a five-step verification checklist for compounded GLP-1 medications.

Are GLP-1 pills safe? Four are FDA-approved in 2026 (Rybelsus, Ozempic tablets, Wegovy tablet, Foundayo). Patient-specific compounded oral GLP-1s through licensed pharmacies are a separate lawful category. No-prescription drops and gummies aren't legitimate. Here's the safety framework, the boxed-warning context, and where PlexusDx oral protocols fit.

How to verify a 503A compounding pharmacy before ordering compounded semaglutide or tirzepatide: eight automatic walk-away triggers, a 10-minute audit using state-board, FDA, PCAB, and NABP databases, and where PlexusDx Weight Management Protocols sit in that framework.